-
Vicriviroc,
previously named SCH 417690 and SCH-D, is a
pyrimidine CCR5
entry inhibitor of HIV-1. It was
developed by the
pharmaceutical company Schering-Plough...
- with
their compound aplaviroc,[citation needed] Schering-Plough with
vicriviroc,[citation needed] and
Pfizer with maraviroc.[citation needed] All of the...
-
Herpes Simplex/Zoster
Valganciclovir (Valcyte)
Cytomegalovirus (CMV)
Vicriviroc HIV-1 Schering-Plough
pyrimidine CCR5
entry inhibitor Vidarabine Herpes...
-
Vibramycin Vicks Formula 44
Vicodin Es
Vicodin Hp
Vicodin Vicoprin Vicoprofen vicriviroc (USAN)
Victoza Victrelis vidarabine (INN)
Vidaza Videx Videx Ec vidofludimus...
- tea,
appears to
interact with gp120 as do
several other theaflavins.
Vicriviroc,
similar to maraviroc, is
currently undergoing clinical trials for FDA...
- NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
- NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
- NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
- co-receptor CCR5.
These experimental drugs include PRO140 (CytoDyn),
Vicriviroc (Phase III
trials were
cancelled in July 2010) (Schering Plough), Aplaviroc...
- NAMs:
Aplaviroc Cenicriviroc (TAK-652, TBR-652) INCB009471
Maraviroc Vicriviroc Antibodies: PRO-140 CCR6 Agonists: CCL20 CCR7 Agonists: CCL19 CCL21 CCR8...
